Phase 1 Eczema Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For Parts 1 & 2 (Healthy Volunteers):
- You are a man or woman aged 18 to 65 years old, in general good health, with a body weight in the normal to slightly overweight range (BMI between 18 and 32)
- Women must either not be able to get pregnant, or must not be sexually active
- Your blood tests, heart trace (ECG), and other health measurements must show no significant problems
For Part 3 (Atopic Dermatitis Patients):
- You are a man or woman aged 18 to 65 years old with a confirmed diagnosis of active atopic dermatitis (eczema), with a BMI of 40 or below
- Your eczema covers at least 10% of your body surface area at the time of screening and at the start of the study
- Your eczema severity, as measured by a standard medical scoring tool (EASI), must be rated at 16 or above at screening and at the start of the study
- A doctor must assess your eczema as at least "moderate" using a standard rating scale at screening and at the start of the study
- Your itch level, rated on a scale of 0–10, must be at least 4 at screening and at the start of the study
Who may not be able to join:
For Parts 1 & 2:
- You have taken any prescription or non-prescription medicines, vitamins, herbal products, or dietary supplements within approximately the last 35 days (or longer, depending on the medicine)
For Part 3:
- You have any significant health condition or abnormal test results that the study doctor believes could put you at risk (confirm with trial site)
- You have certain medical history conditions listed in the full study rules (confirm with trial site)
- You have recently received certain treatments listed in the full study rules (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sitryx Therapeutics, Study Sponsor
Phone: +44 (0)1865 648401
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The Proportion of Participants With Treatment-Emergent Adverse Events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.